COVID-IHU #29

Version 1 du 25 Août 2020
Nullane salus extra ecclesiam
Philippe Gautret, Didier Raoult

Lien vers l’articlehttps://www.sciencedirect.com/science/article/pii/S2052297520300664

Abstract
Randomized clinical trials are not relevant for infectious disease outbreaks due to a new pathogen, for which public health decisions have to be made urgently. An approach based on group comparisons, in silico, may provide valuable results in a reasonably short period of time for a negligible amount of money.

Vous connecter avec vos identifiants

Vous avez oublié vos informations ?